Press release
Lebers Hereditary Optic Neuropathy (LHON) Market Report - Pipeline Review, H2 2017
About Lebers Hereditary Optic Neuropathy Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Pipeline Review, H2 2017, provides an overview of the Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) pipeline landscape.
Lebers hereditary optic neuropathy (LHON) is an inherited form of vision loss. This condition usually begins in a person's teens or twenties, rare cases may appear in early childhood or later in adulthood. Males are affected much more often than females. Symptoms include eye pain or discomfort, numbness, tingling and clouding of vision. Predisposing factors include age, tobacco smoke, alcohol, cancer treating drugs, stress related chemicals, some antibiotics and cyanogens.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1339594
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 1, 3, 2, 3, 1 and 1 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.
Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
View Sample PDF @ https://www.marketresearchreports.biz/reports/1339594/lebers-hereditary-optic-neuropathy-lhon-leber-optic-atrophy-pipeline-review-h2-2017-market-research-reports.pdf
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1339594
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Overview
Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Companies Involved in Therapeutics Development
Alkeus Pharmaceuticals Inc
Biovista Inc
GenSight Biologics SA
Ixchel Pharma LLC
Khondrion BV
Mitotech SA
Spark Therapeutics Inc
Stealth BioTherapeutics Inc
Lebers Hereditary Optic Neuropathy (LHON) (Leber optic atrophy)-Drug Profiles
BVA-202-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BVA-203-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Drug for Lebers Hereditary Optic Neuropathy-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
elamipretide-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate ND4 for Leber's Hereditary Optic Neuropathy-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GS-010-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GS-011-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IXC-201-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
IXC-203-Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KH-176-Drug Profile
Product Description
Mechanism Of Action
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lebers Hereditary Optic Neuropathy (LHON) Market Report - Pipeline Review, H2 2017 here
News-ID: 761988 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Leber
Leber Congenital Amaurosis Market is Projected to be Fueled by Rapid Technologic …
Leber Congenital Amaurosis Market: Overview
Leber congenital amaurosis (LCA) is a disorder of eye mainly affects the retina. Retina is the specific tissue at the back of the eye responsible for detection of light and color. People, primarily babies suffering with this disorder have severe visual impairment from the first year of life. The visual impairment because of this disorder likely to be stable for the rest of the life, whereas…
Global Leber Congenital Amaurosis Syndrome Trends, Regulations and Competitive L …
Leber Congenital Amaurosis
Overview
Leber congenital amaurosis is an eye disorder that primarily affects the retina, which is the specialized tissue at the back of the eye that detects light and color. This condition is the most common cause of inherited blindness in childhood. Symptoms include vision loss, roving eye movements, deep-set eyes, developmental delay, epilepsy, and motor skill impairment.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1248510-leber-congenital-amaurosis-pipeline-review-h1-2017
Leber Congenital Amaurosis Industry Major Outlook
The Pharmaceutical…
Global Leber Congenital Amaurosis Market Trends, Analysis and Forecast to 2024
Leber Congenital Amaurosis Market: Overview
Leber congenital amaurosis (LCA) is a disorder of eye mainly affects the retina. Retina is the specific tissue at the back of the eye responsible for detection of light and color. People, primarily babies suffering with this disorder have severe visual impairment from the first year of life. The visual impairment because of this disorder likely to be stable for the rest of the life, whereas…
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2017
"The Report Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2017, provides an overview of the Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline landscape.
Leber congenital amaurosis is an eye disorder that primarily affects the retina,…
Leber Congenital Amaurosis Market by Players and Application 2024
Leber Congenital Amaurosis Market: Overview
Leber congenital amaurosis (LCA) is a disorder of eye mainly affects the retina. Retina is the specific tissue at the back of the eye responsible for detection of light and color. People, primarily babies suffering with this disorder have severe visual impairment from the first year of life. The visual impairment because of this disorder likely to be stable for the rest of the life, whereas…
Leber Congenital Amaurosis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Leber Congenital Amaurosis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leber Congenital Amaurosis - Pipeline Review, H1 2017, provides an overview of the Leber Congenital Amaurosis (Genetic Disorders) pipeline landscape.
Leber congenital amaurosis is an eye disorder that primarily affects the retina, which is the…
